Novavax, Inc. (NASDAQ:NVAX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

Recs

0
Player Avatar Haugurafpeningum (85.94) Submitted: 11/8/2011 2:32:46 AM : Outperform Start Price: $1.52 NVAX Score: -20.53

Technical Monthly

Featured Broker Partners


Advertisement